The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
COVID
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- COVID-19 (127)
- COVID-19 vaccines (80)
- Advertising (76)
- Prescription medicines (33)
- Regulatory compliance (19)
- Alert/Advisory (15)
- Medicine safety (15)
- Safety (7)
- Disinfectants/Sterilants (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (5)
- Labelling and packaging (3)
- Over the counter (OTC) medicines (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Shortages (2)
- Cosmetics (1)
- Import and export (1)
- Listed medicines (1)
- Medicinal cannabis hub (1)
- Non-prescription medicines (1)
- Scheduling (national classification system) (1)
Collection content
307 result(s) found, displaying 11 to 20
-
GuidanceGuidance for new sponsors on how to supply, import, and export disinfectant products.
-
GuidanceGuidance on the rules governing COVID-19 rapid antigen tests (RATs) advertising.
-
GuidanceGuidance relating to the supply of in vitro diagnostic medical devices for the detection of COVID-19/SARS-CoV-2 infections.
-
GuidanceGuidance clarifying the interaction between our requirements and AHPRA advertising guidelines.
-
GuidanceGuidance to assist manufacturers of medical devices and their component parts with meeting their regulatory obligations.
-
Reference materialInformation to help healthcare organisations update their operating procedures.
-
Reference materialHow to apply for inclusion of face masks (including respirators), that are medical devices, in the Australian Register of Therapeutic Goods (ARTG).
-
Reference materialAnswers to frequently asked questions in relation to rapid antigen point-of-care tests.
-
Reference materialThis document sets out the testing requirements to verify that COVID-19 Rapid Antigen Test (RAT) kits included in the ARTG meet the analytical sensitivity requirements outlined by the World Health Organisation.
-
Reference materialUpdated guidance for businesses using rapid antigen tests approved by the TGA as point-of-care tests.